Bridging Clinic and Lab: Optimizing Treatment for Autoimmune Conditions

A clinician scientist combines clinical work with research to address patient questions, such as the optimal duration of treatment for autoimmune conditions. Immunosuppressive therapies, while effective, carry potential side effects.

The objective is to reduce unnecessary medication and side effects, aiming to improve patient health and quality of life.

The scientist acts as a link between patients and laboratory research, collaborating with scientists to design experiments that address patient-focused inquiries. This work aims to influence clinical practice.

Advancing Care for ANCA-Associated Vasculitis

The research specifically focuses on determining the necessary treatment duration for patients with ANCA-associated vasculitis and predicting disease flares if therapy is stopped. ANCA-associated vasculitis is a rare autoimmune condition that causes inflammation of blood vessels.

While current treatments are effective, the optimal duration of therapy is not yet established. This leads to situations where some patients may receive medication longer than required, while others experience disease flares when treatment is withdrawn.

A laboratory test (assay) is currently under development to predict both treatment response and the likelihood of a disease flare.